Open letter to Karla Soares-Weiser Editor-in-Chief, the Cochrane Collaboration Complaint about Cochrane editors committing editorial misconduct Dear Karla, I hereby complain to you about what I consider editorial misconduct in the Cochrane Common Mental Disorders group. Briefly, while this group imposed ever increasing demands to our protocol about safe withdrawal of depression drugs in patients […]

Systematic violations of patients’ rights and safety: forced medication of a cohort of 30 patients in Alaska Gail Tasch1 and Peter C Gotzsche2 1S8661 Dogwood Road, Eau Claire, WI, USA; 2Institute for Scientific Freedom, Copenhagen, Denmark Correspondence: and This is an accepted manuscript of an article published by Taylor & Francis in Psychosis

We wrote this article on 16 October 2017 but did not upload it. As I think it is still relevant, I have done that now. Psychiatric drug withdrawal: first course in Denmark 16 October 2017 by Professor Peter C. Gøtzsche, the Nordic Cochrane Centre Pharmacist Birgit Toft Pharmacist Bertel Rüdinger Child and adolescent psychiatrist Lisbeth

By Peter C Gøtzsche No wonder the news media are totally silent about the data that show that Sweden’s open society policy was what the rest of the world should have done, too. Numerous studies have shown Sweden’s excess death rate to be among the lowest in Europe during the pandemic and in several analyses,

By Peter C. Gøtzsche and Maryanne Demasi We have published the full review here. Abstract BACKGROUND: Serious and severe harms of the COVID-19 vaccines have been downplayed or deliberately excluded by the study sponsors in high impact medical journals. METHODS: Systematic review of papers with data on serious adverse events (SAEs) associated with a COVID-19

Arranged by number of views as of 20 March 2023. The top one has been seen by half a million people; the list stops at 5,000 views. 2014 Big pharma is organised crime 7min, California 2014 La industria farmacéutica es crimen organizado 7min, California, Spanish subtitles

“Efficacy and safety” and “benefits and risks” of drugs are misleading terms. Words matter. They influence people’s decisions about drugs, other treatments and other interventions. We should therefore abandon misleading terminology and speak about benefits and harms instead. See my BMJ article here. 

Our systematic review of 13 randomised trials (2085 patients) showed that the length of taper was highly predictive for the risk of relapse (P = 0.00001). All the studies we reviewed confounded withdrawal symptoms with relapse; did not use hyperbolic tapering; withdrew the depression drug too fast in a linear fashion; and stopped it entirely

By Peter C Gøtzsche The first sentence in a BMJ article about drug monitoring for bipolar disorder is: “Bipolar disorder often affects a younger population (peak onset between 15 and 19 years)” (1). How is this possible when bipolar disorder in children and young people was virtually unknown 50 years ago? Because bipolar disorder in

By Peter C Gøtzsche, Professor emeritus, Institute for Scientific Freedom Dieting to lose weight is a big industry, but much of the advice offered is not evidence-based. Being a scientist, I reasoned that, to lose weight, you only need to count your calorie intake and expenditure, put it in a spreadsheet, and ensure there is